Jackson Acquisition Co II

Richard Jackson serves as Chairman and CEO of the sponsor entity, Jackson Holdco II LLC, and leads the SPAC's acquisition search and negotiation process (per the firm's SEC filings, 2023). Jackson founded and formerly led Jackson Healthcare, giving him direct operating experience in the sectors the SPAC targets. There is no external management team; the sponsor is run by Jackson and a small group of affiliates from his existing healthcare platform.

Jackson Acquisition Co II is a separate publicly traded entity, but its sponsor, Jackson Holdco II, is controlled by Richard Jackson — the same individual who controls Jackson Healthcare LLC, one of the largest privately held healthcare staffing firms in the U.S. The SPAC prospectus explicitly highlights Jackson Healthcare as a potential source of post-merger operational support, including access to back-office functions, executive talent, and industry relationships. The two entities are not legally consolidated, but share common control through Jackson.

As a SPAC, the vehicle targets a single mature operating company with an enterprise value typically between $600 million and $2 billion — reflecting the standard 'SPAC math' where the target's enterprise value is roughly 2-4x the trust size. The sponsor has indicated a preference for companies generating $50 million to $500 million in annual revenue, which sits in the middle-market growth and mature company segment rather than venture-stage or early-stage businesses (per the firm's SEC filings, 2023). The transaction structure is an acquisition, not a minority investment or growth round.

The SPAC's sourcing relies heavily on Richard Jackson's existing network within the healthcare services industry, developed over two decades through Jackson Healthcare and its affiliated staffing and consulting businesses. The sponsor has also stated it works through traditional investment banking channels and business brokers to identify potential targets. The SPAC's roadshow materials emphasized Jackson's relationships with founder-owned healthcare businesses — companies that may not run broad auction processes and can be reached through industry reputation rather than mass intermediary outreach.

Sectors identified in the SPAC's offering documents include physician practice management, home health and hospice, behavioral health, healthcare IT and revenue cycle management, outsourced pharmaceutical services, and dentistry. The unifying theme is non-acute, outsourced healthcare services that benefit from scale and professionalization — the same type of businesses Jackson Healthcare's staffing platform serves. The sponsor has not disclosed explicit exclusions, though acute-care hospital operators and drug-development biotechnology firms fall outside the stated search scope.

Yes. Richard Jackson's first SPAC, Jackson Acquisition Company, raised $220 million in March 2021 and completed a business combination in 2022 with a healthcare services firm (per the firm's SEC filings, 2021-2022). Jackson Acquisition Co II is the second vehicle under the same sponsor framework, suggesting a repeatable model rather than a one-off capital markets exercise. There is no publicly disclosed third SPAC at this time.

The SPAC's trust agreement requires completion of a business combination within 18 months of the IPO closing — placing the deadline in late 2024 — with the possibility of a shareholder vote to extend the deadline. If no deal completes and no extension is approved, the trust will be liquidated and the funds returned to public shareholders at approximately $10 per share plus any accrued interest. The sponsor's at-risk capital, including the founder shares and private placement warrants, would expire worthless, creating a significant incentive to complete a transaction.